Work Here?
Overview
Altasciences provides an integrated CRO that handles the full early‑phase drug development path, from preclinical testing through clinical proof of concept and into manufacturing. Its approach combines discovery support, safety testing, clinical trial execution, and in‑house manufacturing to run programs under one roof. This contrasts with competitors that require pharma and biotech clients to source services from multiple vendors, adding complexity and risk; Altasciences streamlines the process by coordinating all steps. The company aims to help innovator drug programs move quickly and efficiently, delivering integrated data to de‑risk decisions and speed progression to later stages.
About Altasciences
Industries
Biotechnology
Healthcare
Company Size
1,001-5,000
Company Stage
Early VC
Total Funding
$6.7M
Headquarters
Laval, Canada
Founded
1976
Simplify's Take
What believers are saying
- Biotech sponsors need fewer vendors for early development, shortening timelines and reducing handoffs.
- Certara integration strengthens proof-of-mechanism decisions and improves go-no-go confidence.
- Novo Holdings backing supports expansion into international markets and deeper platform investment.
What critics are saying
- ICON, Labcorp, and Parexel can bundle similar speed claims with larger global reach.
- Low biotech funding pressures utilization, and idle clinics quickly crush CRO/CDMO margins.
- Any manufacturing or data-integrity failure can halt multiple sponsor programs and trigger client exits.
What makes Altasciences unique
- Founded in 1992, Altasciences evolved from Algorithme Pharma into an integrated CRO/CDMO.
- Nine North American facilities support preclinical, clinical, bioanalytical, and manufacturing services.
- The May 2026 Certara partnership adds model-informed drug development directly into execution.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$6.7M
Above
Industry Average
Funded Over
1 Rounds
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Paid Vacation
Paid Sick Leave
Paid Holidays
Employee Assistance & Telehealth Programs
Remote Work Options
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 4%ISELIN, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard...
EcoVadis, the world's most trusted provider of business sustainability ratings, has collaborated closely with Altasciences to enhance its environmental, social, and governance (ESG) initiatives, underscoring the company's commitment to a sustainable future and a reduced environmental footprint.
This partnership combines Altasciences' comprehensive early-phase drug development capabilities with VoxCell's cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment.
For 14 years, Outsourced Pharma's CDMO Leadership Awards have recognized the top-performing contract development and manufacturing organizations based on comprehensive industry research, and feedback from sponsors.
Altasciences receives 2024 CRO Leadership Award for Capabilities.
Altasciences is Hiring for 49 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Altasciences
Industries
Biotechnology
Healthcare
Company Size
1,001-5,000
Company Stage
Early VC
Total Funding
$6.7M
Headquarters
Laval, Canada
Founded
1976
Altasciences is Hiring for 49 Jobs on Simplify!
Find jobs on Simplify and start your career today